ExCellThera’s stem cell expansion approach may benefit AML patients … – News-Medical.net
News-Medical.net |
ExCellThera's stem cell expansion approach may benefit AML patients …
News-Medical.net Patients suffering from acute myeloid leukemia (AML), who require stem cell transplantation as part of their treatment, may now benefit from a new best-in-class process that improves the viability and success of cord blood stem cell transplantation. |
